Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 260

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 260
---
 
    $
    (2.47
    )

    Weighted-average shares outstanding, basic and diluted

    18,662,690

    11,889,193

F-6

TUHURA BIOSCIENCES, INC AND SUBSIDIARIESConsolidated statements of stockholders’ equity (deficit)For the years ended December 31, 2024, and 2023  

    Total

    Additional

    Accumulated

    Stockholders'

    Preferred Stock

    Common Stock

    Paid in

    Equity

    Equity

    Shares

    Dollars

    Shares

    Dollars

    Capital

    (Deficit)

    (Deficit)

    Balances at January 1, 2023
     
    80,606,229

    $
    8,062

    45,286,589

    $
    4,529

    $
    71,449,521

    $
    (59,158,171
    )
     
    $
    12,303,941

    Retroactive application of reverse recapitalization
     
    (63,682,248
    )
     
    $
    8,861

    (37,184,819
    )
     
    $
    3,573

    $
    (12,434
    )
     
    $
    -

    $
    -

    Preferred stock (Series A ratio 1.188, Series A-1 ratio   of 1.132, and Series B ratio of 1.191) converted into   common stock and multiplied by exchange   ratio of 0.1789

    Recast balances, beginning of period (applying   exchange ratio to preferred and common)
     
    16,923,981

    $
    16,923

    8,101,770

    $
    8,102

    $
    71,437,087

    $
    (59,158,171
    )
     
    $
    12,303,941

    Issuance of common shares for asset acquisition
     
    -

    -

    4,065,909

    4,066

    14,995,934

    -

    15,000,000

    Shares repurchased
     
    (11,138
    )

    (10
    )

    -